Distinct tau neuropathology and cellular profiles of an APOE3 Christchurch homozygote protected against autosomal dominant Alzheimer’s dementia
Diego Sepúlveda‐Falla(University Medical Center Hamburg-Eppendorf), Yakeel T. Quiroz(Harvard University)
Cited by 89
Related Papers
Association of Amyloid and Tau With Cognition in Preclinical Alzheimer Disease
|JAMA Neurology|2019|876
Resistance to autosomal dominant Alzheimer’s disease in an APOE3 Christchurch homozygote: a case report
|Nature Medicine|2019|606
Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control study
|The Lancet Neurology|2012|553
World‐Wide FINGERS Network: A global approach to risk reduction and prevention of dementia
|Alzheimer s & Dementia|2020|516
Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological study
|Nature Communications|2020|493